Authors:
RINGE JD
DORST A
KIPSHOVEN C
ROVATI LC
SETNIKAR I
Citation: Jd. Ringe et al., AVOIDANCE OF VERTEBRAL FRACTURES IN MEN WITH IDIOPATHIC OSTEOPOROSIS BY A 3 YEAR THERAPY WITH CALCIUM AND LOW-DOSE INTERMITTENT MONOFLUOROPHOSPHATE, Osteoporosis international, 8(1), 1998, pp. 47-52
Citation: Jd. Ringe, THE INTERPRETATION OF PRECLINICAL DATA IN PREDICTING BISPHOSPHONATE RESPONSE IN THE TREATMENT OF OSTEOPOROSIS, Clinical therapeutics, 20(4), 1998, pp. 648-660
Citation: Jd. Ringe et al., SCREENING FOR LOW BONE MASS IN CROHNS-DISEASE - INCIDENCE OF OSTEOPENIA AND OSTEOPOROSIS IN 253 UNSELECTED CASES, Journal of bone and mineral research, 12, 1997, pp. 672-672
Authors:
HOSKING D
MEUNIER PJ
RINGE JD
REGINSTER JY
GENNARI C
Citation: D. Hosking et al., FORTNIGHTLY REVIEW - PAGETS-DISEASE OF BONE - DIAGNOSIS AND MANAGEMENT, BMJ. British medical journal, 312(7029), 1996, pp. 491-494
Citation: Jd. Ringe et C. Kipshoven, THERAPY OF POSTMENOPAUSAL OSTEOPOROSIS WITH MONOFLUOROPHOSPHATE PLUS CALCIUM - DOSE-DEPENDENT EFFECTS ON BONE-DENSITY AND FRACTURE RATE, Journal of bone and mineral research, 11, 1996, pp. 34-34
Authors:
RINGE JD
REGINSTER JY
GENNARI C
HOSKING DJ
MEUNIER PJ
Citation: Jd. Ringe et al., GUIDELINES FOR AN IMPROVED THERAPEUTIC ST RATEGY IN PATIENTS WITH PAGETS-DISEASE OF BONE, Zeitschrift fur Rheumatologie, 55(4), 1996, pp. 256-259
Authors:
COMPSTON JE
AUDRAN M
AVOUAC B
BOUVENOT G
DEVOGELAER JP
EASTELL R
FABRIS F
GENNARI C
JONES EA
KAUFMAN JM
LEMMEL EM
MAZZUOLI G
REID DM
RINGE JD
VANHAELST L
ZIEGLER R
REGINSTER JY
Citation: Je. Compston et al., RECOMMENDATIONS FOR THE REGISTRATION OF AGENTS USED IN THE PREVENTIONAND TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS, Calcified tissue international, 59(5), 1996, pp. 323-327
Citation: Jd. Ringe et Pj. Meunier, WHAT IS THE FUTURE FOR FLUORIDE IN THE TREATMENT OF OSTEOPOROSIS, Osteoporosis international, 5(2), 1995, pp. 71-74
Citation: Jd. Ringe et al., IS MODERATE HYPOPHOSPHATEMIA A RISK-FACTOR FOR MALE OSTEOPOROSIS, Journal of bone and mineral research, 10, 1995, pp. 240-240
Authors:
COMPSTON JE
REGINSTER JY
JONES EA
KAUFMAN JM
AUDRAN M
BOUVENOT G
FRATI L
MAZZUOLI G
GENNARI C
LEMMEL EM
RINGE JD
SEBERT JL
VANHAELST L
AVOUAC B
Citation: Je. Compston et al., RECOMMENDATIONS FOR THE REGISTRATION OF NEW CHEMICAL ENTITIES USED INTHE PREVENTION AND TREATMENT OF OSTEOPOROSIS, Calcified tissue international, 57(4), 1995, pp. 247-250
Citation: Jd. Ringe et Aj. Dorst, OSTEOPOROSIS IN THE MALE - PATHOGENESIS A ND CLINICAL CLASSIFICATION IN 254 CASES, Deutsche Medizinische Wochenschrift, 119(27), 1994, pp. 943-947
Citation: Jd. Ringe, ALKALINE-PHOSPHATASE AND SERUM-CALCIUM LE VELS IN A FEMALE-ADULT HOSPITALIZED FOR MEASLES, Der Internist, 35(4), 1994, pp. 414-414
Citation: Jd. Ringe et F. Meiss, PREVENTION OF EARLY POSTMENOPAUSAL BONE-D ENSITY LOSS BY TRANSDERMAL ESTROGEN REPLACEMENT, Deutsche Medizinische Wochenschrift, 118(21), 1993, pp. 769-774